Imaging CNS receptors: the dopaminergic system.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001665:Binding Sites; D001921:Brain / Q000000981:diagnostic imaging*; D002250:Carbon Radioisotopes; D003847:Deoxyglucose; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005461:Fluorine; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D010300:Parkinson Disease / Q000000981:diagnostic imaging / Q000378:metabolism; D011868:Radioisotopes; D011954:Receptors, Dopamine / Q000187:drug effects / Q000302:isolation & purification / Q000502:physiology*; D012559:Schizophrenia / Q000378:metabolism; D013134:Spiperone / Q000494:pharmacology; D014055:Tomography, Emission-Computed; D014316:Tritium
D014150:Antipsychotic Agents; D002250:Carbon Radioisotopes; D011868:Radioisotopes; D011954:Receptors, Dopamine; D014316:Tritium; D005461:Fluorine; D013134:Spiperone; D003847:Deoxyglucose; D006220:Haloperidol; D001058:Apomorphine